For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This 42-page report provides detailed analyses of current and emerging hematology and flow cytometry technologies, and their potential market applications, including IT and robotics, lasers, monoclonal antibodies, molecular diagnostics, microdrop and others.
The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 42 pages